Merrimack Pharmaceuticals Inc (MACK)

Hedge Fund Popularity

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Newtyn Management

Noah Levy And Eugene Dozortsev

1,713,612 $10,830 +11% 2.59%
2.
Bronte Capital

John Hempton

578,313 $3,658 +8% 0.3%
3.
Nantahala Capital Management

Wilmot B. Harkey And Daniel Mack

516,817 $3,269 -10% 0.14%
4. 341,685 $2,161 0%
5.
Two Sigma Advisors

John Overdeck And David Siegel

23,181 $147 -10% 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$5.13 132 Officer, Director 126,004 2022-05-25 Filing
$5.09 2,323 Officer, Director 125,872 2022-05-24 Filing
$5.04 512 Officer, Director 123,549 2022-05-19 Filing
$5.08 5,000 Officer, Director 123,037 2022-05-18 Filing
$5.10 225 Officer, Director 118,037 2022-05-17 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$3.84 1,000 Director 0 2021-12-31 Filing
$6.39 52,914 Director, Other 269,338 2021-07-01 Filing
$3.20 6,228 Officer, Director 0 2020-07-22 Filing
$3.20 17,250 Officer, Director 0 2020-07-22 Filing
$3.04 52,068 Officer, Director 0 2020-07-22 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 1,241,896 $7,855 2.85%
2. 1,172,463 $6,800 6.45%
3. 608,204 $3,847 0%
4. 482,484 $3,052 0%
5. 296,546 $1,876 0.16%
News See All